However, future studies comparing MSA patients with other neurodegenerative conditions, such as Parkinson's disease and dementia with Lewy bodies, could help to explore whether FGF14 expansions are uniquely associated with MSA or are part of a broader neurodegenerative spectrum. This evidence concerns the gene FGF14 and multiple system atrophy.